Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting

(2011) Giorgio Guazzoni et al.   EUROPEAN UROLOGY

PSA and Beyond: The Past, Present, and Future of Investigative Biomarkers for Prostate Cancer

(2011) Jeffrey Tosoian et al.   TheScientificWorldJOURNAL

Evaluation of Zinc-α-2-Glycoprotein and Proteasome Subunit β-Type 6 Expression in Prostate Cancer Using Tissue Microarray Technology

(2010) Gillian OʼHurley et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

(2009) Arun Sreekumar et al.   NATURE

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prostate cancer: a serious disease suitable for prevention

(2008) John M. Fitzpatrick et al.   BJU INTERNATIONAL

Search for Potential Markers for Prostate Cancer Diagnosis, Prognosis and Treatment in Clinical Tissue Specimens Using Amine-Specific Isobaric Tagging (iTRAQ) with Two-Dimensional Liquid Chromatography and Tandem Mass Spectrometry

(2008) Spiros D. Garbis et al.   JOURNAL OF PROTEOME RESEARCH

2D-DIGE as a Strategy To Identify Serum Markers for the Progression of Prostate Cancer

(2008) Jennifer C. Byrne et al.   JOURNAL OF PROTEOME RESEARCH

Annexin A3 in Urine: A Highly Specific Noninvasive Marker for Prostate Cancer Early Detection

(2008) Martin Schostak et al.   JOURNAL OF UROLOGY